Role of an improvement in acid-base status and nutrition in CAPD patients. Short-term correction of metabolic acidosis in normal and uremic subjects has been shown to decrease protein degradation, but the long-term effects of better correction of acidosis on nutrition in ESRF are unknown. The aim of this study was to assess the possible benefits, in the nutritional state and morbidity, of improved correction of acidosis in the first year of treatment with continuous ambulatory peritoneal dialysis (CAPD). Two hundred consecutive new CAPD patients were randomized, in a single-blind fashion, to receive a high (HA; lactate 40 mmol/liter) or low (LA; lactate 35 mmol/liter) alkali dialysate for one year. Calcium carbonate and sodium bicarbonate were also used to correct acidosis in the HA group. At one year, the venous serum bicarbonate and arterial pH were 7.44 0.004 and 27.2 0.3 mmol/liter in the HA group, and 23.0 0.3 mmol/liter and 7.4 0.004 in the LA group (P < 0.001). Dialysis dose, at one year or at the point of leaving the study (HA 8.0 0.1 liters/day vs. LA 8.5 0.3 liters/day) was not significantly different (P = 0.18). At one year, the increase in body weight in the HA group (6.1 0.66 kg) was higher than in the LA group (3.71 0.56 kg, P < 0.05). The increase in midarm circumference in the HA patients (1.26 0.16 cm) was significantly higher than the increase in the LA patients (0.61 0.16 cm, P < 0.05). The increase in triceps skinfold thickness were not significantly different (HA 2.5 0.41 mm vs. LA 1.24 0.38 mm, P 0.1). Serum albumin was 37.8 0.4 g/dl at one year in the HA group, and 38.2 0.5 g/dl in the LA group (NS). Dietary protein intake at one year (HA 0.9 0.2 g/kglday vs. LA 1.0 0.1 g/kg/day) was not significantly different. There were fewer hospital admissions in the HA group (1.13 0.16 per patient per year) compared to the LA group (1.71 0.22 per patient per year, P < 0.05). The HA patients spent less days in hospital per year than the LA patients (16.4 1.4 days/year vs. 21.2 1.9 days/year; P < t).05). It is concluded that better correction of metabolic aeidosis leads to greater increases in body weight and midarm circumference, hut not triceps skinfold thickness, in the first year of CAPD. The improvement in morbidity, in terms of number of admissions and days in hospital per year, may be associated with the improvement in nutritional state.
sustained on an acid rather than alkali generating diet [1] . There is considerable circumstantial evidence that MA plays a dominant role in the malnutrition associated with chronic renal failure. In retrospective studies, better correction of acidosis has been shown to improve the reduced growth velocity of children with chronic renal failure [2] . Furthermore, correcting the metabolic acidosis in patients with non-uremic renal tubular acidosis also improves growth [31.
Short-term prospective studies in animals and humans have confirmed these observations, by demonstrating links between MA and protein metabolism. It has been shown that the induction of MA in animals with chronic renal failure causes increased muscle proteolysis [4] that can be reversed with the administration of sodium bicarbonate. Furthermore, correction of acidosis has been shown to reduce protein degradation in predialysis patients [5, 6] , and patients on peritoneal dialysis [71 and hemodialysis [8] . The induction of MA in animals increases urea production [4] , an effect reversed by the addition of sodium bicarbonate in both animals [4] and humans [5, [7] [8] [9] .
In rats, muscle branch chain amino acid degradation, like protein degradation, is increased in uraemia acidosis; and, as with protein degradation, sodium bicarbonate reverses this abnormality [10] . In patients with chronic renal failure, branch chain amino acid (BCAA) degradation is accelerated and plasma BCAA levels are low [111. Finally, there is a strong positive linear correlation between plasma bicarbonate levels and free valine concentration in the muscle of hemodialysis patients [12] .
Whether this effect, or more particularly the reversal of this eflèct, has any clinical relevance for patients with chronic renal failure in the long-term remains unknown. The aim of this study was to assess the possible benefits, in terms of nutritional state and morbidity, of improved correction of acidosis in the first year of continuous ambulatory peritoneal dialysis (CAPD).
METHODS
Permission for the study was granted by the Ethical Committee of Leicestershire Health Authority. Consent was obtained from 200 consecutive new CAPD who were randomized, in a single-blinded fashion, to receive a high alkali (HA; lactate 40 mmol/liter) or low alkali (LA; lactate 35 mmol/liter) dialysatc, and studied for one year. The HA dialysate contained less calcium than the LA dialysate (HA, ionized calcium concentration 1.25 mmol/liter vs. LA 1.75 mmol/liter). All patients were treated by CAPD from the start of renal replacement therapy, and were recruited between December 1992 and December 1994. Baseline (time 0) was defined as the day before CAPD catheter insertion (or the day before the first hemodialysis if appropriate).
Patients were assessed at 0, 1, 3, 6, 9 and 12 months. At the majority of outpatient appointments, the patients were seen by one physician (As).
Matching
The two groups were compared in terms of epidemiological data, causes of renal failure, nutritional state and laboratory parameters. Data were recorded at baseline or at one month (indicated in Results).
At baseline, a comorbidity score (maximum = 7) was calculated for each patient. One 'point' was scored for the presence of diabetes mellitus (not necessarily the cause of renal failure), ischemic heart disease, cerebrovascular disease, peripheral vascular disease, serious malignancy, left ventricular failure and any other serious comorbid disease.
Laboratory parameters
Serum bicarbonate and albumin were measured at the six designated time points, using standard laboratory techniques.
Serum cortisol was measured at 1 and 12 months.
Acid-base balance
The target venous bicarbonate level in the HA group was 30 mmol/liter. If this was not achieved with HA dialysate and CaCO3 alone, oral sodium bicarbonate was added at a dose of 0.6 g three times per day, and increased to a maximum of 1.8 g tds. In the LA group the venous bicarbonate was ignored, unless a patient was considered to be symptomatic of acidosis. Arterial pH was measured from a radial artery sample at one year.
Nutritional assessment
The nutritional state was assessed by experienced renal dieticians. Body weight (without CAPD fluid in the abdomen at baseline, and thereafter with CAPD fluid in the abdomen if the patient was still on CAPD) was measured at 0, 1, 6 and 12 months. Midarm circumference and triceps skinfold thickness were measured at 1, 6 and 12 months. Serum albumin was measured at all six assessment points. At one year, a 7-day food record was used to assess dietary protein intake.
Bone metabolism A target serum calcium of 2.5 mmol/Iiter was used for both groups. In order to achieve maximal correction of acidosis in the HA group and minimal safe correction of acidosis in the LA group, the method of achieving the target serum phosphate was different in the two groups.
In 
Dialysis dose
The majority of patients were started on four 2-liter exchanges per day. Dialysis adequacy was assessed using 'conventional' monitoring of serum urea and creatinine levels. The dialysis dose was increased if the patient recorded either a serum urea of over 30 mmol/liter or creatinine over 1200 p.mol/liter. The dialysis dose was decreased if both the serum urea fell to below 15 mmol/liter and the creatinine to below 500 jimol/liter, in the absence of clinical evidence of malnutrition. Urea kinetic modeling was performed at 1, 6 and 12 months, but it should be noted that treatment was not adjusted according to the results. The patients were advised on a regular basis to adhere to a dietary protein intake of 1.0 g/kg/day with an adequate calorie intake. The dieticians were not aware of which dialysis fluid/tablet regime was being used.
Morbidity
Morbidity was assessed in terms of the number of admissions per year, and days spent in hospital per year. The number of admissions included only those after the insertion of CAPD catheter. The days spent in hospital included all admissions for one year after discharge from the admission that incorporated the CAPD catheter insertion, any admission(s) immediately before the CAPD catheter insertion, and the admission for the insertion of the CAPD catheter.
Outcomes Seven outcome states were recognized at one year: (1.) CAPD (whether or not the patient had received a failed transplant, a temporary period of haemodialysis or intermittent peritoneal dialysis, or temporary recovery of renal function); (2.) functioning HD or IPD before death, transplantation, transfer out or recovery of renal function.
Analysis
Results were analyzed on an 'intention-to-treat' basis, that is, patients remained in the group into which they were first randomized. Data are presented as means standard error of the mean. The data and graphs presented include all data from the patients who had reached that time point. Data after a patient had been transferred out of the unit was not included in the analysis.
Statistical analysis, using the unpaired Student's t-test, compared the two groups at one year. 
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RESULTS

Matching
The two groups were well matched at baseline, in terms of epidemiological data, causes of renal failure, nutritional state and laboratory parameters (Tables I and 2 ). Table 2 also summarizes the one year data.
Acid/base balance To achieve the target serum bicarbonate level of 30 mmol/liter and target serum calcium of 2.5 mmol/liter, 92 of the HA patients (at one year or the point of leaving the study) required calcium carbonate (at an average dose of 2.91 0.16 g per day) as well as HA dialysate. Thirty-six of the LA patients required calcium carbonate (0.63 0.11 g per day; P < 0.001). Aluminium hydroxide was used in 3 of the HA patients compared to 17 of the LA patients, Alphacalcido! was used in 29 HA patients compared to 46 LA patients (average dose 0.13 0.02 .tg per day vs. 0.22 0.03 .tg per day; P < 0.05).
Forty-eight of the HA patients (at one year or the point of leaving the study) also required sodium bicarbonate (at an average dose of 1.4 0.17 g per day) to achieve the target serum bicarbonate level. One LA patient required sodium bicarbonate because of symptoms thought to be due to persistent severe acidosis. Two LA patients had to be changed to I-IA dialysate because of persistent hypercalcemia, despite withdrawal of calcium containing or sustaining agents.
At one year, the arterial pH and venous serum bicarbonate were 7.44 0.004 and 27.2 0.3 mmol/liter in the HA group, and 23.0 0.3 mmol/liter and 7.4 0.004 in the LA group (both P < 0.001). Serum bicarbonate levels are shown in Figure 1 .
There was no difference in systolic or diastolic blood pressure at one year between the two groups: 130 2/78 1 mm Hg in the HA group versus 129 3/76 1 mm Hg in the LA group.
Furthermore, there was no difference in the number of antihypertensive drugs used by the two groups at one year.
Nutritional state
At one year, the increase in body weight in the HA group (6.1 (166 kg) was significantly greater than the LA group (3.7] 0.56 kg; Fig. 2 ; P < 0.05); as was the increase in midarm circumference (HA patients 1.26 0.16 cm; LA patients 0.61 0.16 cm; Fig. 3 ; P < 0.05). The increases in triceps skinfold thickness were not significantly different (HA 2.5 0.41 mm vs. LA 1.24 0.38 mm).
Serum albumin was not different at one year (Table 2) . Dietary protein intake at one year (HA 0.9 0.2 g/kg/day vs. LA 1.0 0.1 g/kg/day) was not significantly different. Bone metabolism
The target adjusted serum calcium of 2.5 mmol/liter was achieved by six months in both groups (Fig. 4) . At one year, the calcium was not significantly different in the two groups. Serum phosphate was lower in the HA patients at one year, when compared to the LA patients (HA 1.66 mmol/liter vs. LA 1.87 mmol/liter; P < 0.05; Fig. 5 ). There was no difference in parathyroid hormone levels between the two groups at one year ( Figure  6 ). There were two parathyroidectomies in the HA group, compared to none in the LA group.
Dialysis dose
Before one year, there were 17 increases and 6 decreases dialysis dose in the HA group, compared to 18 and 9 in the LA group. At one year or at the point of leaving the study, out of the HA group, 11 patients were using 1.5 liter exchanges, 74 2-liter, 14 2.5-liter and one 3-liter exchanges. In the LA group, 11 patients were using 1.5 liter exchanges, 71 2-liter, 13 2.5-liter and five 3-liter exchanges. Dialysis dose, at one year or at the point of leaving the study (HA 8.0 0.1 liters/day vs. LA 8.5
0.3 liters/day) was not significantly different (P = 0.18).
Protein catabolic rates, weekly urea Kt/V and weekly creatinine clearances were not significantly different at one year in the two groups (Table 2) .
Morbidity
There were fewer hospital admissions in the HA group (1.13 0.16 per patient per year) compared to the LA group (1.71 0.22 per patient per year; P < 0.05). The HA patients spent fewer days in hospital per year than the LA patients (16.4 1.4 days/year vs.
21.2
1.9 days/year; P < 0.05).
Outcomes
The treatment modality of the two groups at one year is summarized in Table 3 . A similar number of patients were transplanted in the two groups (15 in the HA group, 17 in the LA group). Six patients in each group experienced permanent technique failure. Twelve patients died in the HA group, compared to 15 in the LA group. The causes of technique failure and death are summarized in Table 4 .
DISCUSSION
Preliminary studies have indicated that the control of MA might have an influence on the long-term nutritional state of peritoneal dialysis patients. in a two-week prospective uncontrolled study of 11 peritoneal dialysis patients, serum bicarbonate was increased from a mean of 26 mmol/liter to 30 mmol/liter [7] . Total 15 12 This was associated with a significant reduction in protein catabolic rate, as urea excretion diminished, despite a constant dietary intake of protein. In a one-year uncontrolled retrospective study, a much larger group of CAPD patients who had been on dialysis for over 18 months was investigated [13] . There was a significant improvement in body weight and midarm circumference when the serum bicarbonate was increased from a mean of 23.7 to 31.5 mmol/liter. The aim of the present study was to confirm or refute this effect by means of a large prospective, controlled single-blind study.
The two groups were well matched at baseline. If anything, the HA were the 'less well' group at baseline with 22 patients with diabetes mellitus, compared to 12 in the LA group. The starting weight of the HA was also slightly lower (68 vs. 69.1 kg).
Even though the different dialysate/medication regimes were able to produce differences in control of acid-base balance, the target venous bicarbonate of 30 mmol/liter in the HA group, was surprisingly difficult to achieve. At one year or at the point of leaving the study, 92 of the 100 HA patients required calcium carbonate and/or sodium bicarbonate to achieve the target serum bicarbonate level.
Despite this, at one year, only 17 out of 69 CAPD patients (24.6%) who reached that time point had a venous bicarbonate of 30 mmol/liter or over, compared to none in the LA group. Part of this difficulty can be explained by examining Figure 2 . It can be seen that after three months, there was a progressive decline in venous bicarbonate in both groups, presumably as a result of the loss of residual renal function. Furthermore, it appears that the amount of lactate in HA dialysate (40 mmol/liter), even in combination with high dose calcium carbonate and/or sodium bicarbonate, was insufficient to achieve higher bicarbonate levels. Not surprisingly, it was more difficult to improve acidosis correction in the larger patients, especially those losing residual renal function. Also, it is doubtful that when large doses of calcium carbonate and/or sodium bicarbonate were prescribed, compliance with either drug was optimal.
It is interesting that the effects seen in this study were observed when neither group was alkalotic or acidotic. Indeed, the effects on weight gain and midarm circumference observed occurred at the ends of the normal range of serum venous bicarbonate. In the majority of the animal studies carried out so far, in which acidosis has been shown to increase protein degradation, thc animals were made profoundly acidotic; for example, in one rat study, art arterial pH of 7.2 was achieved [141. It is conceivable, however, whatever the mechanism of this effect, that it is clinically relevant in patients with end-stage renal failure, within their range of acid-base balance. As sodium bicarbonate was rcquircd to fully correct acidosis in many patients in the HA group, it could be argued that their greater weight gain was secondary to sodium and water retention. However, if this was the case, one would not expect blood pressure control to be so similar in the two groups. Furthermore, there was no significant differencc in the number of antihypertensive agents by each group. One might also have expected more hospital admissions in the HA group, due to fluid overload. In fact, there were less admissions in the HA group.
In terms of nutritional state, this was a very positive study. At one year, the increase in body weight in the HA group was significantly higher than in the LA group (6.1 vs. 3.7 kg). When the 2 kg of the weight gain that can be apportioned to the CAPD fluid in the abdomen is 'removed' from the analysis, the size of this effect can be appreciated even more. In other words, the 4.1 kg of true body weight gain in the HA patients is nearly 2.5 times the 1.7 kg weight gain in the LA group. Interestingly, there was no significant relationship between starting weight and weight gain in the HA group (r = 0.11; P > 0.35), indicating that the positive effect seen is apparent over the whole range of patient size, not just those 'with most to gain,' that is, the malnourished patients. The increase in midarm circumference at one year in the HA patients was significantly higher than the increase in the LA patients (1.26 vs. 0.61 cm), the size of the effect being of similar proportion to that of the weight gain. The increases in triceps skinfold thickness (2.5 vs. 1.24 mm), though not statistically significant, may have been biologically relevant. Comparing the two groups, the serum albumin was the same throughout the study, and appeared to slowly rise in both groups during the study.
That lack of difference in serum albumin in the two groups probably reflects the poor quality of the parameter as a nutritional marker.
That there was no difference in serum calcium at one year was, in part, related to the design of the study. A serum adjusted calcium of 2.5 mmol/liter was one of the target parameters used in the study, in an attempt to control for variables other than acid/base balance. Not surprisingly, as five times the dose of calcium carbonate was prescribed in the HA patients (in an attempt to make them more alkalotic) the phosphate control was better in that group. This 'benefit' did not lead to better parathyroid hormone control. Indeed, there were two parathyroidectomies in the HA group and none in the LA group. This study was not designed to investigate the mechanism of any beneficial effect seen. Nonetheless, some information can he gained from the data collected, accepting that these data did not reach statistical significance. Even though the protein catabolic rates, weekly urea Kt/V and weekly creatinine clearances were not significantly different at one year, when the direction of change in values is examined, interesting effects can he seen. All three parameters (which are proportional to urea or creatinine excretion, and thereby reflect muscle breakdown as well as dialysis dose) decreased (from 0.92 g/kglday, 1.89 and 76.9 liters per week at one month to 0.89, 1.85 and 76.3, respectively, at twelve months) in the HA group, despite an overall tendency to an increase in dialysis dose over the year. This suggests that there may have been a decrease in muscle breakdown in the HA patients over the year of study. Whereas, in the LA group, two out of three parameters increased (from 0.88 g/kg/day, 1.93 and 78.2 liters per week at one month to 0.94, 1.91 and 80.1 at twelve months). Indeed, by as early as one month, there was a trend towards greater kinetic modeling parameters in the LA group (Table 2 ). This may indicate that there was an increase in muscle breakdown in the LA group.
The serum cortisol was significantly higher at one year in the HA group compared to the LA group (544.6 23 vs. 431 10.8 mmol/liter). This finding is difficult to interpret, as studies carried out so far, indicate that the increase in protein breakdown associated with metabolic acidosis is mediated, in part, by an increase in glucocorticoid secretion [15] .
Whatever the mechanism of the effect, it seems likely that a true metabolic change had occurred, rather than the HA patients simply ate more, particularly as the dietary protein intake was not significantly different in the two groups at one year.
In terms of morbidity, the HA patients also fared better than the LA group as there were significantly less hospital admissions in the HA group. The HA patients spent, on average, 5 days less in hospital per year than the LA patients. This apparently small improvement in hospitalization could have major economic benefits in terms of the cost of CAPD per year, as well as lifestyle benefits to the patient, if reproduced in large dialysis populations. The statistical power of this study was never great enough for it to be a mortality study. It was not designed to show an improvement in mortality even if a better nutritional state did produce such a gain. However, it is gratifying that there were 12 deaths in the HA group compared to 15 in the LA group.
In conclusion, better correction of metabolic acidosis leads to greater increases in body weight and midarm circumference in 
